She is also a Taubman Scientist at the A. Alfred Taubman Medical Research Institute. In her research, Kelly uses epigenetic epidemiology to test the combined genetic and environmental etiology of neurological disorders throughout the life course. She develops biomarker tools in highly collaborative studies with mechanistic toxicologists. She has studied mental health issues such as autism spectrum disorder, substance abuse, and Alzheimer’s disease. Kelly commonly assesses risk from exposure to heavy metals, endocrine disrupting chemicals, and nutritional metabolites. Kelly completed a postdoctoral fellowship at Johns Hopkins University in the Department of Epidemiology and Center for Epigenetics. She has a BS from Colby College and a PhD in Environmental Health Sciences from the University of Michigan.